Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL672488 | 1.00 | LMNA (0.38) | LMNATHRB | |
| SCHEMBL10826755 | 1.00 | LMNA (0.38) | LMNATHRB | |
| SCHEMBL31135124 | 1.00 | LMNA (0.38) | LMNATHRB | |
| SCHEMBL5188413 | 0.97 | LMNA (0.33) | LMNA | |
| SCHEMBL10826113 | 0.90 | — | — | |
| SCHEMBL10826142 | 0.90 | — | — | |
| SCHEMBL10826125 | 0.90 | — | — | |
| SCHEMBL2864416 | 0.87 | — | — | |
| Ethyne SCHEMBL10826121 | 0.87 | — | — | |
| SCHEMBL10826124 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240166658-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | UNIVERSITY OF TASMANIA (AU) | 2024-05-23 | — | — | US | disclosed |
| EP-4298101-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | University Of Tasmania (AU) | 2024-01-03 | — | — | EP | disclosed |
| WO-2022178593-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | UNIVERSITY OF TASMANIA (AU) | 2022-09-01 | — | — | WO | disclosed |
| US-20050272599-A1 | Mold release layer | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2005-12-08 | — | — | US | disclosed |
| US-5698169-A | USING DICARBOLLIDE OR DICARBAEXTRANIDE COMPLEX; ION EXCHANGING | COREMETALS RESEARCH, INC. (US) | 1997-12-16 | — | — | US | disclosed |
| WO-1996039702-A2 | METHODS AND AGENTS FOR THE EXTRACTION OF CESIUM AND STRONTIUM FROM NUCLEAR WASTE | COREMETALS RESEARCH, INC. (US) | 1996-12-12 | — | — | WO | disclosed |
| US-3983179-A | BLOOD OXYGEN TRANSPORTS | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166658-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | PFAS, PCBP1, FGR | LMNA 4166/4885THRB 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.